Back to top

Stifel Nicolaus Sticks to Their Buy Rating for Evommune, Inc. (EVMN)

In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Evommune, Inc., with a price target of $54.00. Thomps...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: